Soy Protein Supplementation Is Associated With Improved Renal Function and Selected Inflammatory Markers in Patients With Advanced Diabetic Nephropathy

Read full text Summarise with VIRAT
Authors: Shy-Fen Huang, Shiaw-Wen Chien, Jiun‐Rong Chen
Cited by: 0
References: 40

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Diabetic nephropathy (DN) is a leading cause of end-stage renal disease worldwide, yet effective nutritional interventions remain limited. This study evaluated whether soy protein supplementation could improve renal function, metabolic parameters, and inflammatory markers in patients with advanced DN. We hypothesized that soy protein has beneficial effects on renal function and oxidative stress and can improve the progression in patients with end-stage DN. This trial was registered at clinicaltrials.gov (NCT05840796). Forty-five DN outpatients were recruited from Tung's Taichung MetroHarbor Hospital (Taichung City, Taiwan) and randomly separated into the soy protein and casein groups. The soy protein group was given a soy protein drink (n = 24, 2 packages/day), and the casein group was given a casein drink ( n = 21, 2 packages/day) for 4 months. The blood pressure, plasma glucose, lipid profile, renal function (estimated glomerular filtration rate, eGFR), and inflammatory factor levels were analyzed at baseline and at the end of the study. Compared to the baseline, blood glucose and TG levels significantly decreased in the soy protein group, whereas only blood glucose levels decreased significantly in the casein group. Moreover, the soy protein group's eGFR level was significantly increased after 4 months of intervention. In addition, both the soy protein and casein groups showed significantly lower sICAM-1 levels, indicating reduced inflammation. In conclusion, soy protein supplementation significantly reduced blood glucose and TG levels and improved renal function in DN patients. These findings should be interpreted cautiously given the relatively small sample size and high attrition rate.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Dialysis and Renal Disease Management Renal Diseases and Glomerulopathies

Publication details

Journal / source
JAND Global Reports
Volume
3
Pages
100014–100014
Publication date
31 March 2026
Language
EN